Nicholas J. Donato
Affiliations: | The University of Texas Graduate School of Biomedical Sciences at Houston |
Area:
Molecular Biology, OncologyGoogle:
"Nicholas Donato"Children
Sign in to add trainee
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Potu H, Kandarpa M, Peterson LF, et al. (2021) Downregulation of SOX2 by inhibition of Usp9X induces apoptosis in melanoma. Oncotarget. 12: 160-172 |
| Potu H, Kandarpa M, Peterson LF, et al. (2019) Tumor necrosis factor related apoptosis inducing ligand (TRAIL) regulates deubiquitinase USP5 in tumor cells. Oncotarget. 10: 5745-5754 |
| Pal A, Dziubinski M, Di Magliano MP, et al. (2017) Usp9x Promotes Survival in Human Pancreatic Cancer and Its Inhibition Suppresses Pancreatic Ductal Adenocarcinoma In Vivo Tumor Growth. Neoplasia (New York, N.Y.). 20: 152-164 |
| Potu H, Peterson LF, Kandarpa M, et al. (2017) Usp9x regulates Ets-1 ubiquitination and stability to control NRAS expression and tumorigenicity in melanoma. Nature Communications. 8: 14449 |
| Peterson LF, Lo MC, Liu Y, et al. (2017) Induction of p53 suppresses chronic myeloid leukemia. Leukemia & Lymphoma. 1-14 |
| Passalacqua KD, Charbonneau ME, Donato NJ, et al. (2016) Anti-infective activity of 2-cyano-3-acrylamide inhibitors with improved drug-like properties against two intracellular pathogens. Antimicrobial Agents and Chemotherapy |
| Curi DA, Beauchamp EM, Blyth GT, et al. (2015) Pre-clinical evidence of PIM kinase inhibitor activity in BCR-ABL1 unmutated and mutated Philadelphia chromosome-positive (Ph+) leukemias. Oncotarget. 6: 33206-16 |
| Chou DH, Vetere A, Choudhary A, et al. (2015) Kinase-Independent Small-Molecule Inhibition of JAK-STAT Signaling. Journal of the American Chemical Society. 137: 7929-34 |
| Peterson LF, Sun H, Liu Y, et al. (2015) Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies. Blood. 125: 3588-97 |
| Potu H, Peterson LF, Kandarpa M, et al. (2015) Abstract 3621: Deubiquitination of AXIN1 by USP9X promotes apoptosis in melanoma in response to BRAF or MEK inhibition Cancer Research. 75: 3621-3621 |